# Nutanix, Inc.: overview

NTNX · Nasdaq · CIK 1618732 · [Technology](/sectors/technology.md) · fiscal year ends Jul 31

Pages: [Overview](/companies/ntnx.md) · [Financials](/companies/ntnx/financials.md) · [Filings](/companies/ntnx/filings.md) · [Insiders](/companies/ntnx/insiders.md)

Latest reported revenue: [$757.1m](/filings/0001193125-26-394793.md) for Q4 FY2026, three months to 2026-07-31, from the 10-K filed Sep 18, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001193125-26-394793).

## Last eight quarters

| Line item | Unit | Q1 FY2025 (2024-10-31) | Q2 FY2025 (2025-01-31) | Q3 FY2025 (2025-04-30) | Q4 FY2025 (2025-07-31) | Q1 FY2026 (2025-10-31) | Q2 FY2026 (2026-01-31) | Q3 FY2026 (2026-04-30) | Q4 FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [591](/filings/0001193125-25-308095.md) | [655](/filings/0001193125-26-085397.md) | [639](/filings/0001193125-26-248282.md) | [653 d](/filings/0001193125-26-394793.md) | [671](/filings/0001193125-25-308095.md) | [723](/filings/0001193125-26-085397.md) | [703](/filings/0001193125-26-248282.md) | [757 d](/filings/0001193125-26-394793.md) |
| Gross margin | % | [86.0%](/filings/0001193125-25-308095.md) | [87.0%](/filings/0001193125-26-085397.md) | [87.0%](/filings/0001193125-26-248282.md) | [87.2% d](/filings/0001193125-26-394793.md) | [87.0%](/filings/0001193125-25-308095.md) | [87.4%](/filings/0001193125-26-085397.md) | [86.9%](/filings/0001193125-26-248282.md) | [86.0% d](/filings/0001193125-26-394793.md) |
| Operating margin | % | [4.6%](/filings/0001193125-25-308095.md) | [10.0%](/filings/0001193125-26-085397.md) | [7.6%](/filings/0001193125-26-248282.md) | [4.8% d](/filings/0001193125-26-394793.md) | [7.4%](/filings/0001193125-25-308095.md) | [11.6%](/filings/0001193125-26-085397.md) | [10.0%](/filings/0001193125-26-248282.md) | [9.2% d](/filings/0001193125-26-394793.md) |
| Net margin | % | [5.1%](/filings/0001193125-26-248282.md) | [8.6%](/filings/0001193125-26-248282.md) | [9.9%](/filings/0001193125-26-248282.md) | [5.9% d](/filings/0001193125-26-394793.md) | [9.3%](/filings/0001193125-26-248282.md) | [14.3%](/filings/0001193125-26-248282.md) | [10.3%](/filings/0001193125-26-248282.md) | [167.7% d](/filings/0001193125-26-394793.md) |
| Diluted EPS | $ per share | [0.10](/filings/0001193125-25-308095.md) | [0.19](/filings/0001193125-26-085397.md) | [0.22](/filings/0001193125-26-248282.md) | not reported | [0.21](/filings/0001193125-25-308095.md) | [0.36](/filings/0001193125-26-085397.md) | [0.25](/filings/0001193125-26-248282.md) | not reported |
| Free cash flow | $m | [152](/filings/0001193125-25-308095.md) | [187 d](/filings/0001193125-26-085397.md) | [203 d](/filings/0001193125-26-248282.md) | [208 d](/filings/0001193125-26-394793.md) | [175](/filings/0001193125-25-308095.md) | [191 d](/filings/0001193125-26-085397.md) | [197 d](/filings/0001193125-26-248282.md) | [278 d](/filings/0001193125-26-394793.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 6-month figure less the 3-month figure; 9-month figure less the 6-month figure; 12-month figure less the 9-month figure.

## Last five fiscal years

| Line item | Unit | FY2022 (2022-07-31) | FY2023 (2023-07-31) | FY2024 (2024-07-31) | FY2025 (2025-07-31) | FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,581](/filings/0000950170-24-108159.md) | [1,863](/filings/0001193125-25-213801.md) | [2,149](/filings/0001193125-26-394793.md) | [2,538](/filings/0001193125-26-394793.md) | [2,854](/filings/0001193125-26-394793.md) |
| Gross margin | % | [79.7%](/filings/0000950170-24-108159.md) | [82.2%](/filings/0001193125-25-213801.md) | [84.9%](/filings/0001193125-26-394793.md) | [86.8%](/filings/0001193125-26-394793.md) | [86.8%](/filings/0001193125-26-394793.md) |
| Operating margin | % | [(29.0%)](/filings/0000950170-24-108159.md) | [(11.1%)](/filings/0001193125-25-213801.md) | [0.4%](/filings/0001193125-26-394793.md) | [6.8%](/filings/0001193125-26-394793.md) | [9.6%](/filings/0001193125-26-394793.md) |
| Net margin | % | [(50.5%)](/filings/0000950170-24-108159.md) | [80.9%](/filings/0001193125-26-394793.md) | [(5.8%)](/filings/0001193125-26-394793.md) | [7.4%](/filings/0001193125-26-394793.md) | [52.8%](/filings/0001193125-26-394793.md) |
| Diluted EPS | $ per share | [(3.62)](/filings/0000950170-24-108159.md) | [(1.09)](/filings/0001193125-25-213801.md) | [(0.51)](/filings/0001193125-26-394793.md) | [0.65](/filings/0001193125-26-394793.md) | [5.17](/filings/0001193125-26-394793.md) |
| Free cash flow | $m | [18.5](/filings/0000950170-24-108159.md) | [207](/filings/0001193125-25-213801.md) | [598](/filings/0001193125-26-394793.md) | [750](/filings/0001193125-26-394793.md) | [841](/filings/0001193125-26-394793.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/ntnx/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $2.02bn | 39,607,144 |  | Reduced −228,874 |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $1.42bn | 27,768,774 |  | Added +458,701 |
| [AQR CAPITAL MANAGEMENT LLC](/funds/1167557.md) | 2026-06-30 | $901.2m | 17,778,710 |  | Added +2,624,196 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $682.9m | 13,400,084 |  | Reduced −609,141 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $587.3m | 11,524,693 |  | Reduced −555,632 |
| [GOLDMAN SACHS GROUP INC](/funds/886982.md) | 2026-06-30 | $486.4m | 9,545,567 |  | Added +5,094,148 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $418.0m | 8,201,648 |  | Added +102,029 |
| [GENERATION INVESTMENT MANAGEMENT LLP](/funds/1375534.md) | 2026-06-30 | $341.9m | 6,709,160 |  | Reduced −794,661 |
| [Bank of New York Mellon Corp](/funds/1390777.md) | 2026-06-30 | $289.8m | 5,687,665 |  | Added +3,792,304 |
| [Jericho Capital Asset Management L.P.](/funds/1525234.md) | 2026-06-30 | $288.8m | 5,668,014 |  | Added +1,747,518 |

## Recent filings

[All 1,028 filings](/companies/ntnx/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-20 | 21:05 ET | [DEF 14A](/filings/0001193125-26-426829.md) | Proxy statement, period 2026-12-11 | 0001193125-26-426829 |
| 2026-10-07 | 20:30 ET | [8-K](/filings/0001193125-26-417007.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-417007 |
| 2026-09-24 | 13:00 ET | [8-K](/filings/0001193125-26-400318.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-400318 |
| 2026-09-18 | 00:42 ET | [10-K](/filings/0001193125-26-394793.md) | Annual report, period 2026-07-31 | 0001193125-26-394793 |
| 2026-08-26 | 20:01 ET | [8-K](/filings/0001171843-26-005752.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-005752 |
| 2026-08-04 | 13:00 ET | [8-K](/filings/0001193125-26-331661.md) | 2.05 Exit or disposal costs | 0001193125-26-331661 |
| 2026-05-29 | 20:10 ET | [10-Q](/filings/0001193125-26-248282.md) | Quarterly report, period 2026-04-30 | 0001193125-26-248282 |
| 2026-05-27 | 20:01 ET | [8-K](/filings/0001171843-26-003724.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-003724 |
| 2026-05-05 | 00:06 ET | [8-K](/filings/0001193125-26-204667.md) | 3.02 Unregistered sale of equity | 0001193125-26-204667 |
| 2026-04-07 | 20:08 ET | [8-K](/filings/0001171843-26-002298.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-002298 |

## Latest annual report

[Form 10-K for the fiscal year ended Jul 31, 2026](/filings/0001193125-26-394793.md), filed Sep 18, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1618732
- Tickers: NTNX
- Exchange: Nasdaq
- SIC code: 7372 Services-Prepackaged Software
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:44 ET. No prices; not investment advice.